BrainStorm will attend the DUPHAT pharmaceuticals conference in Dubai on Aug. 25-27, 2026.
Executive Chairman Peter J. Pitts is scheduled to deliver two keynote addresses, including on FDA policy coordination tied to the Abraham Accords.
Management plans regional meetings with regulators, distribution partners, investors to support NurOwn positioning ahead of a planned Phase 3b ENDURANCE trial.
BCLI•
